24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Corporate
Appointments
Tech Gateways
@Finance
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Therapix Biosciences
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
21:03
Apple's Intel bet faces a long wait
10:00
“Human intelligence must stay in control of AI”
09:00
You will never own the AI. You can still own what it cannot.
17:27
“I lost almost $300,000 in four minutes”: How an alleged WhatsApp pump-and-dump scheme played out
More stories
Buzz
Most popular
Daily
Weekly
1
Cyberbit shuts down Israeli operations, lays off local workforce
2
AI startup Engram raises $98 million at $600 million valuation with just 13 employees
3
Assaf Rappaport’s 2026 deal spree: Inside the Wiz founder’s expanding AI investment map
4
“I will have nothing when I leave this world” — Daniel Jusidman on philanthropy and giving away his fortune at 91
5
The 50 most promising Israeli startups - 2026
More news
Therapix Biosciences
1 stories about Therapix Biosciences
Canada's FSD Pharma to Acquire Israeli Therapix Biosciences for $48 Million in Stock
23.10.18
|
Lilach Baumer
Clinical-stage Therapix Biosciences develops cannabinoid-based drugs for the treatment of neurological conditions, pain management, and infectious diseases
